Bioactivation of nephrotoxic haloalkenes by glutathione conjugation: formation of toxic and mutagenic intermediates by cysteine conjugate beta-lyase. 1989

W Dekant, and S Vamvakas, and M W Anders
Institut für Toxikologie, Universität Würzburg, F.R.G.

UI MeSH Term Description Entries
D007674 Kidney Diseases Pathological processes of the KIDNEY or its component tissues. Disease, Kidney,Diseases, Kidney,Kidney Disease
D008190 Lyases A class of enzymes that catalyze the cleavage of C-C, C-O, and C-N, and other bonds by other means than by hydrolysis or oxidation. (Enzyme Nomenclature, 1992) EC 4. Desmolase,Desmolases,Lyase
D009153 Mutagens Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. Clastogen,Clastogens,Genotoxin,Genotoxins,Mutagen
D005978 Glutathione A tripeptide with many roles in cells. It conjugates to drugs to make them more soluble for excretion, is a cofactor for some enzymes, is involved in protein disulfide bond rearrangement and reduces peroxides. Reduced Glutathione,gamma-L-Glu-L-Cys-Gly,gamma-L-Glutamyl-L-Cysteinylglycine,Glutathione, Reduced,gamma L Glu L Cys Gly,gamma L Glutamyl L Cysteinylglycine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006846 Hydrocarbons, Halogenated Hydrocarbon compounds with one or more HYDROGEN atoms substituted with HALOGENS. Halogenated Hydrocarbons
D000475 Alkenes Unsaturated hydrocarbons of the type Cn-H2n, indicated by the suffix -ene. (Grant & Hackh's Chemical Dictionary, 5th ed, p408) Alkene,Olefin,Olefins,Pentene,Pentenes
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001711 Biotransformation The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.
D013437 Carbon-Sulfur Lyases Enzymes that catalyze the cleavage of a carbon-sulfur bond by means other than hydrolysis or oxidation. EC 4.4. Sulfhydrases,Carbon Sulfur Lyases,Lyases, Carbon-Sulfur

Related Publications

W Dekant, and S Vamvakas, and M W Anders
May 1986, The Journal of biological chemistry,
W Dekant, and S Vamvakas, and M W Anders
January 1998, Annual review of pharmacology and toxicology,
W Dekant, and S Vamvakas, and M W Anders
October 2004, Drug metabolism reviews,
W Dekant, and S Vamvakas, and M W Anders
November 1995, Applied and environmental microbiology,
W Dekant, and S Vamvakas, and M W Anders
January 1981, Methods in enzymology,
W Dekant, and S Vamvakas, and M W Anders
May 1983, Molecular pharmacology,
W Dekant, and S Vamvakas, and M W Anders
January 1985, Methods in enzymology,
W Dekant, and S Vamvakas, and M W Anders
January 1999, Journal of cancer research and clinical oncology,
W Dekant, and S Vamvakas, and M W Anders
January 1991, Chemico-biological interactions,
Copied contents to your clipboard!